Drug-Coated Balloon for Acute Myocardial Infarction: A Meta-Analysis of Randomized Clinical Trials

Published: 15 September 2021| Version 2 | DOI: 10.17632/7jfhpxtpww.2
Yuxuan Zhang,


Our research hypothesis that DCB might be a feasible interventional strategy in treatment of patients with Acute Myocardial Infarction (AMI). Our data shows that DCB might be a feasible interventional strategy versus control as it associated with comparable clinical outcomes in the treatment of AMI. Future large-volume, well-designed randomized controlled trials to evaluating the role of the DCB in this setting are warranted. All data in this research, including major adverse cardiac events (MACEs); target lesion revascularization (TLR); myocardial infarction (MI); cardiovascular mortality; all-cause mortality; stent thrombosis; minimum lumen diameter (MLD) and late lumen loss (LLL), was come from other articles. You can get those data through this research or the articles which this research included.



Zhejiang University - Huajiachi Campus


Reference Material, Supplementation